Clinical trial
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS): Study Protocol for a Multicenter Randomized Controlled Trial
NCT06791031 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS): Study Protocol for a Multicenter Randomized Controlled Trial
- Lead sponsor
- West China Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- June 30, 2028
- Enrollment
- 212 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.